Pages that link to "Q38929380"

The following pages link to IgGA: a "cross-isotype" engineered human Fc antibody domain that displays both IgG-like and IgA-like effector functions. (Q38929380):

Displaying 23 items.

• Advances in Therapeutic Fc Engineering - Modulation of IgG-Associated Effector Functions and Serum Half-life (Q28079016) (← links)
• Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo (Q33889191) (← links)
• The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease (Q34499286) (← links)
• Macrophages are critical effectors of antibody therapies for cancer (Q36213288) (← links)
• Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding (Q36216363) (← links)
• The role of Fc receptors in HIV prevention and therapy (Q37113972) (← links)
• Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting (Q37138332) (← links)
• Engineering broadly neutralizing antibodies for HIV prevention and therapy (Q38717198) (← links)
• IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions (Q38730371) (← links)
• Immunoglobulin A: magic bullet or Trojan horse? (Q38778020) (← links)
• Neutrophils in cancer (Q38936555) (← links)
• IgG Fc variant cross-reactivity between human and rhesus macaque FcγRs (Q39038535) (← links)
• Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going? (Q42372842) (← links)
• Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy (Q42660162) (← links)
• An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIa Reveals That Ligation of FcγRIIIa Mediates Potent Antibody Dependent Cellular Phagocytosis With GM-CSF-Differentiated Macrophages (Q64111519) (← links)
• Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life. (Q64928870) (← links)
• Monoclonal antibody-mediated killing of tumour cells by neutrophils (Q88943760) (← links)
• Antibody-mediated complement activation in pathology and protection (Q90107838) (← links)
• Allosteric Effects between the Antibody Constant and Variable Regions: A Study of IgA Fc Mutations on Antigen Binding (Q90212270) (← links)
• An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence (Q91151392) (← links)
• Topical application of human-derived Ig isotypes for the control of acute respiratory infection evaluated in a human CD89-expressing mouse model (Q92145072) (← links)
• Production, characterization, and in vivo half-life extension of polymeric IgA molecules in mice (Q92248471) (← links)
• Considerations for the Design of Antibody-Based Therapeutics (Q92585782) (← links)